Bridgewater Associates, LP Cierra Posición En GILD / Gilead Sciences, Inc

20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io Fintel ®

Ingrese el término de búsque 

Fondos Baker Brothers Advisors Baupost Group Berkshire Hathaway Bridgewater Associates Cascade Investment Chatham Asset Management Duquesne Family Office Gotham Asset Management Mangrove Partners Melvin Capital Perceptive Advisors Point72 Asset Management Renaissance Technologies Sabby Management Scion Asset Management Starboad Value Third Point Insiders Elon Musk Lisa Su Evan Spiegel Jeff Bezos Cribadores Advanced Screener Sample Screens Community Screens

Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Herramientas Hedge Fund Holdings Tracker Combined Portfolios Tool Finpedia Latest Activist 13D/G Filings Latest 13F Filings Latest Insider Trades Activist Investor List Top Investors by AUM Industry Data Machine Learning and AI Tools Fintel Labs  Iniciar sesión En línea Bridgewater Associates, LP cierra posición en GILD / Gilead Sciences, Inc.

Descargar Tiempo de sueños

Uso de las relaciones Put / Call para comprender el sentimiento institucional La propiedad institucional es una medida popular, pero defectuosa, del sentimiento institucional porque incluye participaciones significativas de instituciones pasivas que invierten sin la debida diligencia

Los fondos más sofisticados utilizan opciones de compra y venta para cubrir sus inversiones La comparación de la proporción de opciones de compra y venta (la relación Put / Call) es una medida más precisa del sentimiento institucional https://fintel.io/so/us/gild/bridgewater-associates-lp 1/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io Los índices de Put / Call institucionales agregados para acciones están disponibles para los miembros Premium en las páginas de propiedad de acciones

Haga clic para comenzar (solo lleva unos segundos)

Fintel es utilizado por estas excelentes organizaciones.

Seguridad GILD / Gilead Sciences, Inc. Institución Bridgewater Associates, LP Gerente Ray Dalio, príncipe Bob Comparte 0 0 Valor $ 0

Bridgewater Associates, LP cierra posición en GILD / Gilead Sciences, Inc.

13 de febrero de 2020: Bridgewater Associates, LP ha presentado un formulario 13F-HR que revela la propiedad de 0 acciones de Gilead Sciences, Inc. (NASDAQ: GILD) con tenencias totales valoradas en $ 0 USD al 31 de diciembre de 2019. Bridgewater Associates, LP había presentado un 13F-HR anterior el 13 de noviembre de 2019, revelando 122,718 acciones de Gilead Sciences, Inc. por un valor de $ 7,778,000 USD. Esto representa un cambio en las acciones de -100.00 por ciento y un cambio en el valor de -100.00 por ciento durante el trimestre.

Otros inversores con posiciones cerradas incluyen Gamco Investors, Inc. Et Al , Tourbillon Capital Partners, LP , Clinton Group Inc , Jarislowsky, Fraser Ltd y Balyasny Asset Management Llc .

Presentaciones 13F

Las columnas de Seguridad, Clase e ID en la tabla a continuación se muestran exactamente como archivadas por el inversionista. Hacemos nuestro mejor esfuerzo para rastrear la continuidad de las inversiones a través de adquisiciones, y esto se reflejará en la tabla como cambios en los nombres y CUSIP. Además de los datos descriptivos, el rendimiento de la inversión se muestra con el tiempo. Para calcular el rendimiento trimestral, primero calculamos la base del costo de las acciones compradas durante el trimestre, luego la usamos para calcular la ganancia bruta. El rendimiento trimestral es el beneficio bruto / valor de la cartera inicial.

Tenga en cuenta que la base de costos se calcula y almacena en miles, por lo que pequeños cambios trimestrales en las acciones con frecuencia resultan en una base de costos de cero.

Actualice para desbloquear datos premium y exporte a Excel .

Precio Base Acciones Valor CARNÉ DE medio Valor Asignación de Beneficio Retorno Fecha de Formar Seguridad Clase Comparte modificadas cambiado IDENTIDAD de la (x1000) (%) costos (x1000) (%) vigencia (%) (%) acción (x1000) CIENCIAS 2018-06-30 13F DE COM 375558103          GILEAD CIENCIAS 2017-03-31 13F DE COM 375558103          GILEAD CIENCIAS 2016-12-31 13F DE COM 375558103          GILEAD CIENCIAS 2016-09-30 13F DE COM 375558103          GILEAD CIENCIAS 2016-06-30 13F DE COM 375558103          GILEAD CIENCIAS 2016-03-31 13F DE COM 375558103          GILEAD CIENCIAS 31/12/2015 13F DE COM 375558103          GILEAD CIENCIAS 2015-09-30 13F DE COM 375558103          GILEAD CIENCIAS 2015-06-30 13F DE COM 375558103          GILEAD CIENCIAS 2015-03-31 13F DE COM 375558103          GILEAD CIENCIAS 2014-12-31 13F DE COM 375558103          GILEAD CIENCIAS 2014-09-30 13F DE COM 375558103          GILEAD CIENCIAS 2014-06-30 13F DE COM 375558103          GILEAD CIENCIAS 2014-03-31 13F DE COM 375558103          GILEAD CIENCIAS 31/12/2013 13F DE COM 375558103          GILEAD

Registros relacionados con la SEC

GILD / Gilead Sciences, Inc. / VANGUARD GROUP INC Inversión pasiva

02-11 sec.gov gileadsciencesinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: Gilead Sciences Inc Title of Class of Securities: Common Stock CUSIP Number: 375558103 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: (X) Rule 13d-1(b) ( ) Rule 13d-1(c) ( ) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter

GILD / Gilead Sciences, Inc. / BlackRock Inc. Passive Investment

02-04 sec.gov https://fintel.io/so/us/gild/bridgewater-associates-lp 3/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

us3755581036_020419.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9) GILEAD SCIENCES INC ------(Name of Issuer) Common Stock ------(Title of Class of Securities) 375558103 ------(CUSIP Number) December 31, 2018 ------(Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be

GILD / Gilead Sciences, Inc. / Capital Research Global Investors - SC 13G Passive Investment

02-14 sec.gov UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Gilead Sciences, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 375558103 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

GILD / Gilead Sciences, Inc. / VANGUARD GROUP INC Passive Investment

02-11 sec.gov gileadsciencesinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: Gilead Sciences Inc Title of Class of Securities: Common Stock CUSIP Number: 375558103 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropriate box https://fintel.io/so/us/gild/bridgewater-associates-lp 4/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

to designate the rule pursuant to which this Schedule is filed: (X) Rule 13d-1(b) ( ) Rule 13d-1(c) ( ) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter

1 GILD / Gilead Sciences, Inc. / Capital Research Global Investors - SC 13G Passive Investment

02-14 sec.gov - 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Gilead Sciences, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 375558103 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. Related News Stories

19 Obscure Model Puts a Price on Good Health—and Drives Down Drug Costs - WSJ

11-04 wsj.com - 1 The makers of the cholesterol-lowering drug Praluent, which first went on sale for $14,600, offered to sell it for as little as $4,500, after rebates. A new migraine drug called Aimovig, expected to cost up to $10,000 a year, went on sale for $6,900. And Zolgensma, a lifesaving gene therapy for children that its maker said might cost up to $5 million, was priced at $2.1 million. https://fintel.io/so/us/gild/bridgewater-associates-lp 5/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

SNY VRTX REGN AMGN GILD GCVRZ NVS SAN CI CVS SNYNF

12 REFILE-Humira, Rituxan top list of U.S. costliest drug price increases -report

10-08 reuters.com NEW YORK, Oct 8 (Reuters) - AbbVie Inc’s arthritis drug Humira and Roche Holding AG’s cancer drug Rituxan top the list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion increase in U.S. spending, a report released on Tuesday showed. PFZ AMGN GILD ROG PFIZER RHHBF RHHVF BIIB RHHBY ABBV 500680 PFE RO ABBV

40 The 8 Best Cash Cow Stocks to Buy for Stable Returns

08-14 investorplace.com - 2 [Editor’s note: “The 8 Best Cash Cow Stocks to Buy for Stable Returns” was previously published in March 2019. It has since been updated to include the most relevant information available.] BCE PM AFL GILD GOOGL GOOG MCD PAYX ATVI

38 3 Big Stock Charts for Monday: Xilinx, News Corp and Gilead Sciences

08-12 investorplace.com Thursday’s gain felt a little too strong to trust, and sure enough, it didn’t last. The S&P 500 fell 0.66% on Friday, leaving it squarely in the middle of equally important support and resistance levels. NKTR XLNX GJV GE GEC AMGN NWS GILD NWSA GNE GE.WI NWSAL https://fintel.io/so/us/gild/bridgewater-associates-lp 6/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

22 FOCUS-Patient groups push back against Gilead's pricey HIV prevention treatment

08-07 reuters.com LOS ANGELES (Reuters) - Gilead Sciences Inc (GILD.O) hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker faces opposition from an unusual source: patient advocates. TEVJF GILD TEVA TEVVF CI

4 Gilead results beat Street estimates as demand grows for HIV drug

07-31 cnbc.com The category is picking up the slack for declining iPhone sales and includes Apple Watch, AirPods wireless earbuds and Beats headphones. GILD GLPG SMSN GPS

1 Gilead Through The Eyes Of A Dividend Growth Investor - Gilead Sciences, Inc. (NASDAQ:GILD) | Seeking Alpha

07-29 seekingalpha.com - 1 Now that the sales decline comes to an end, Gilead looks like an attractive dividend growth stock to me. GLPGF GILD

Will Strong HIV Sales Drive Gilead's (GILD) Q2 Earnings? https://fintel.io/so/us/gild/bridgewater-associates-lp 7/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

07-26 zacks.com Biotech major Gilead Sciences Inc. (GILD - Free Report) is slated to report second-quarter results on Jul 30, after the market closes. REGN GILD INCY GLPG

Gilead Increases Stake in Galapagos with 10-Year Deal Worth More than $5 Billion

07-15 biospace.com Cuatro meses después de informar el éxito en dos ensayos de artritis reumatoide con su socio de desarrollo Galapagos NV, Gilead Sciences está fortaleciendo esa asociación con una colaboración global de investigación y desarrollo de 10 años por un valor de más de $ 5 mil millones. Gilead también está aumentando su participación en Galápagos. GILD GLPG

2 Alexion recibe la aprobación de la FDA para la expansión de etiquetas de Soliris

06-28 zacks.com - 1 Alexion Pharmaceuticals, Inc. (ALXN - Informe gratuito) anunció que la FDA aprobó una expansión de la etiqueta del medicamento con plomo, Soliris (eculizumab). ALXN GILD AKTX CLTX ACHN

CUSIP: 375558103 ISIN: US3755581036 Último precio y tamaño del lote 74.93 / 100 a https://fintel.io/so/us/gild/bridgewater-associates-lp 8/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

partir del 20/03/2020, 1:44:12 PM ET

https://fintel.io/so/us/gild/bridgewater-associates-lp 9/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

https://fintel.io/so/us/gild/bridgewater-associates-lp 10/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

https://fintel.io/so/us/gild/bridgewater-associates-lp 11/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

https://fintel.io/so/us/gild/bridgewater-associates-lp 12/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

https://fintel.io/so/us/gild/bridgewater-associates-lp 13/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

Institutional and Hedge Fu…

Insider Trading Tutorial - b…

Sitios que disfrutamos QuantSoft Capital Partners: aplicación del aprendizaje automático en los mercados de capitales Finpedia - Ciencias de Galaad WolfStreet RealInvestmentAdvice

Anuncio

Crea, Conduce, Destrózalo Todo

crossout.net VISITAR

https://fintel.io/so/us/gild/bridgewater-associates-lp 14/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

Anuncio

Crea, Conduce, Destrózalo Todo

crossout.net VISITAR

Anuncio

Medición de conductividad - Guía de teoría gratuita

METTLER TOLEDO ABIERTO

https://fintel.io/so/us/gild/bridgewater-associates-lp 15/16 20/3/2020 Bridgewater Associates, LP closes position in GILD / Gilead Sciences, Inc. - 13F, 13D, 13G Filings - Fintel.io

Herramientas para inversores

Herramienta de acciones combinadas

Cree su propio portafolio de alta convicción combinando las posiciones de los fondos líderes e identificando las acciones más comúnmente mantenidas

Probar ahora Advanced Stock Screener

Analice el mercado de ideas de inversión utilizando expresiones complejas.

Probar ahora Hedge Fund Holdings Tracker

Encuentre ideas de inversión de alta convicción examinando las tenencias combinadas de instituciones líderes

Probar ahora

Fintel® provides advanced research tools for data-driven investors Fintel currently tracks over 9500 funds and over 63,000 securities traded worldwide. Information includes fund holdings, fund sentiment, financial data, and regulatory filings (including SEC, LSE, ASX, and SGX).

Este sitio web se proporciona "tal cual" sin ninguna representación o garantía, expresa o implícita. Fintel no hace representaciones ni garantías en relación con este sitio web o la información y los materiales proporcionados en este sitio web. Nada en este sitio web constituye, o pretende constituir, asesoramiento de ningún tipo. Si necesita asesoramiento en relación con cualquier asunto financiero, debe consultar a un profesional apropiado. Datos de precios en tiempo real proporcionados por IEX . Datos del tablero de mensajes proporcionados por SiliconInvestor .

En construcción: el sitio web está siendo escaneado por cookies por primera vez.

https://fintel.io/so/us/gild/bridgewater-associates-lp 16/16